Cited by 630Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial

Open access

Dysken, Maurice W., Sano, Mary, Asthana, Sanjay, Vertrees, Julia E., Pallaki, Muralidhar, Llorente, Maria, Love, Susan, Schellenberg, Gerard D., McCarten, J. Riley, Malphurs, Julie, Prieto, Susana, Chen, Peijun, Loreck, David J., Trapp, George, Bakshi, Rajbir S., Mintzer, Jacobo E., Heidebrink, Judith L., Vidal-Cardona, Ana, Arroyo, Lillian M., Cruz, Angel R., Zachariah, Sally, Kowall, Neil W., Chopra, Mohit P., Craft, Suzanne, Thielke, Stephen, Turvey, Carolyn L., Woodman, Catherine, Monnell, Kimberly A., Gordon, Kimberly, Tomaska, Julie, Segal, Yoav, Peduzzi, Peter N., Guarino, Peter D.·2014·JAMA

DOI 10.1001/jama.2013.282834PMC PMC4109898

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. OBJECTIVE: To determine if vitamin E (alpha tocopherol), memantine, or both slow progression of mild to moderate AD in patients taking an acetylcholinesterase inhibitor. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, parallel-group, randomized clinical trial involving 613 patients with mild to moderate AD initiated in August 2007 and concluded in September 2012 at 14 Veterans Affairs medical centers. INTERVENTIONS: Participants received either 2000 IU/d of alpha tocopherol (n = 152), 20 mg/d of memantine (n = 155), the combination (n = 154), or placebo (n = 152). MAIN OUTCOMES AND MEASURES: Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Inventory score (range, 0-78). Secondary outcomes included cognitive, neuropsychiatric, functional, and caregiver measures. RESULTS: Data from 561 participants were analyzed (alpha tocopherol = 140, memantine = 142, combination = 139, placebo = 140), with 52 excluded because of a lack of any follow-up data. Over the mean (SD) follow-up of 2.27 (1.22) years, ADCS-ADL Inventory scores declined by 3.15 units (95% CI, 0.92 to 5.39; adjusted P = .03) less in the alpha tocopherol group compared with the placebo group. In the memantine group, these scores declined 1.98 units less (95% CI, -0.24 to 4.20; adjusted P = .40) than the placebo group's decline. This change in the alpha tocopherol group translates into a delay in clinical progression of 19% per year compared with placebo or a delay of approximately 6.2 months over the follow-up period. Caregiver time increased least in the alpha tocopherol group. All-cause mortality and safety analyses showed a difference only on the serious adverse event of "infections or infestations," with greater frequencies in the memantine (31 events in 23 participants) and combination groups (44 events in 31 participants) compared with placebo (13 events in 11 participants). CONCLUSIONS AND RELEVANCE: Among patients with mild to moderate AD, 2000 IU/d of alpha tocopherol compared with placebo resulted in slower functional decline. There were no significant differences in the groups receiving memantine alone or memantine plus alpha tocopherol. These findings suggest benefit of alpha tocopherol in mild to moderate AD by slowing functional decline and decreasing caregiver burden. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00235716.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2013.282834

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Self-citation
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043

Show all 40 references

Sorted by citations

Items 301–400 of 630

Effects of Aging and Tocotrienol‐Rich Fraction Supplementation on Brain Arginine Metabolism in Rats
Mazlan, M., Hamezah, H. S., Taridi, N. M., Yu, J. H., Liu, P., Zhang, H., Ngah, W. Z. W., & Damanhuri, H. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6019796 · Cited by 17
Alzheimer dementia: Starting, stopping drug therapy
Kim, L. D., & Factora, R. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.16080 · Cited by 19
Copper accumulation in the brain causes the elevation of oxidative stress and less anxious behavior in Ts1Cje mice, a model of Down syndrome
Ishihara, K., Kawashita, E., Shimizu, R., Nagasawa, K., Yasui, H., Sago, H., Yamakawa, K., & Akiba, S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.015 · Cited by 17
Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's disease
Ren, J., Xiang, B., Xueling, L., Han, X., Yang, Z., Zhang, M., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36470 · Cited by 16
Insights on Localized and Systemic Delivery of Redox‐Based Therapeutics
Buglak, N., Batrakova, E. V., Mota, R. I., & Bahnson, E. M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2468457 · Cited by 18
Testing whether the progression of Alzheimer’s disease changes with the year of publication, additional design, and geographical area: a modeling analysis of literature aggregate data
Zhang, N., Zheng, X., Liu, H., Zheng, Q., & Li, L. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00630-5 · Cited by 16
Research progress of ferroptosis in Alzheimer disease: A review
Han, Q., Sun, L., & Xiang, K. (2023) · Medicine · doi:10.1097/md.0000000000035142 · Cited by 16
Higher dietary butyrate intake is associated with better cognitive function in older adults: evidence from a cross-sectional study
Tu, J., Zhang, J., & Chen, G. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1522498 · Cited by 16
Dementia
Fisher, T., Schwartz, A., Greenspan, H. N., & Heinrich, T. W. (2016) · International Journal of Psychiatry in Medicine · doi:10.1177/0091217416636579 · Cited by 19
Bayesian accrual prediction for interim review of clinical studies: open source R package and smartphone application
Jiang, Y., Guarino, P., Ma, S., Simon, S. D., Mayo, M. S., Raghavan, R., & Gajewski, B. J. (2016) · Trials · doi:10.1186/s13063-016-1457-3 · Cited by 17
Measuring informed consent capacity in an Alzheimer's disease clinical trial
Guarino, P., Vertrees, J. E., Asthana, S., Sano, M. C., Llorente, M. D., Pallaki, M., Love, S. B., Schellenberg, G. D., & Dysken, M. W. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.09.001 · Cited by 16
Modulation of Proteome Profile in AβPP/PS1 Mice Hippocampus, Medial Prefrontal Cortex, and Striatum by Palm Oil Derived Tocotrienol-Rich Fraction
Hamezah, H. S., Durani, L. W., Yanagisawa, D., Ibrahim, N. F., Aizat, W. M., Makpol, S., Ngah, W. Z. W., Damanhuri, H. A., & Tooyama, I. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181171 · Cited by 16
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
Tassone, G., Kola, A., Valensin, D., & Pozzi, C. (2021) · Life · doi:10.3390/life11050386 · Cited by 16
Bombycis excrementum Reduces Amyloid-β Oligomer-Induced Memory Impairments, Neurodegeneration, and Neuroinflammation in Mice
Moon, M., Choi, J. G., Kim, S. Y., & Oh, M. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140270 · Cited by 16
Vitamin E for Alzheimer's disease?
Simonson, W. (2014) · Geriatric Nursing · doi:10.1016/j.gerinurse.2014.02.003 · Cited by 16
Biological determinants of blood-based biomarker levels in Alzheimer’s disease: role of nutrition, inflammation, and metabolic factors
Inamdar, A., Bugadannavar, P., Palled, M. S., Umarani, S., Salve, P. S., Gurupadayya, B., Patil, P. D., & Sharma, H. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1614962 · Cited by 21
Effects of water‐soluble mangosteen extract on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's disease (WECAN‐AD): A randomized controlled trial
Muangpaisan, W., Wiputhanuphongs, P., Jaisupa, N., Junnu, S., Samer, J., Moongkarndi, P., Supapueng, O., Chalermsri, C., & Neungton, N. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12292 · Cited by 15
Over the Counter Supplements for Memory: A Review of Available Evidence
Hersant, H., He, S., Maliha, P., & Grossberg, G. T. (2023) · CNS Drugs · doi:10.1007/s40263-023-01031-6 · Cited by 19
Endogenous chemicals guard health through inhibiting ferroptotic cell death
Song, Y., Lei, H.-X., Dou, Y., Zhu, H., Hao, M., Cui, R., Meng, X., Sheng, X. D., & Zhang, L. (2023) · BioFactors · doi:10.1002/biof.2015 · Cited by 18
Influence of variety and growing location on carotenoid and vitamin E contents of 184 different durum wheat varieties (Triticum turgidum ssp. durum) in Germany
Groth, S., Wittmann, R., Longin, C. F. H., & Böhm, V. (2020) · European Food Research and Technology · doi:10.1007/s00217-020-03557-1 · Cited by 15
Vitamin and mineral supplementation for prevention of dementia or delaying cognitive decline in people with mild cognitive impairment
Abraham, R. P., Denton, D. A., Al-Assaf, A. S., Rutjes, A. W., Chong, L. Y., Malik, M., & Tabet, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011905 · Cited by 16
Comparing monolithic and fused core HPLC columns for fast chromatographic analysis of fat-soluble vitamins
Kurdi, S. E., Muaileq, D. A., Alhazmi, H. A., Bratty, M. A., & Deeb, S. E. (2017) · Acta Pharmaceutica · doi:10.1515/acph-2017-0013 · Cited by 15
The Effects of Dietary Fermented Soybean Meal Supplementation on the Growth, Antioxidation, Immunity, and mTOR Signaling Pathway of Juvenile Coho Salmon (Oncorhynchus kisutch)
Zhang, Q., Yang, Q., Guo, M., Li, F., Qin, M., Xie, Y., Xu, J., Liu, Y., & Tong, T. (2023) · Fishes · doi:10.3390/fishes8090448 · Cited by 14
The Effects of High-Intensity Interval Training with Supplementation of Flaxseed Oil on BDNF mRNA Expression and Pain Feeling in Male Rats
Rahmati-Ahmadabad, S., Azarbayjani, M. A., & Nasehi, M. (2017) · Annals of Applied Sport Science · doi:10.29252/aassjournal.5.4.1 · Cited by 14
Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease
Belitskaya‐Lévy, I., Dysken, M. W., Guarino, P., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M. D., Love, S. B., & Schellenberg, G. D. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.001 · Cited by 14
Alzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome
Giulietti, A., Vignini, A., Nanetti, L., Mazzanti, L., Primio, R. D., & Salvolini, E. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150928155321 · Cited by 14
Tocopherol suppresses 24(S)-hydroxycholesterol-induced cell death via inhibition of CaMKII phosphorylation
Kimura, Y., Asa, M., Urano, Y., Saito, Y., Nishikawa, K., & Noguchi, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.004 · Cited by 14
Vitamin E, Memantine, and Alzheimer Disease
Evans, D. A., Morris, M. C., & Rajan, K. B. (2013) · JAMA · doi:10.1001/jama.2013.282835 · Cited by 14
Is vitamin supplementation appropriate in the healthy old?
Dharmarajan, T. S. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000150 · Cited by 13
Methods for assessment of Vitamin E
Leonard, S. W., & Traber, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813050-6.00004-8 · Cited by 13
α-tocopherol, a slow-binding inhibitor of acetylcholinesterase
Zueva, I. V., Lushchekina, S. V., Shulnikova, P., Lenina, O. A., Petrov, K. A., Molochkina, E. M., & Masson, P. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109646 · Cited by 13
Cross‐sectional and longitudinal assessments of function in prodromal‐to‐mild Alzheimer's disease: A comparison of the ADCS‐ADL and A‐IADL‐Q scales
Teng, E., Li, Y., Manser, P. T., Pickthorn, K., Butcher, B. D., Blendstrup, M., RANDOLPH, C. C., & Sikkes, S. A. M. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12452 · Cited by 13
The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs
Corbett, A., & Ballard, C. G. (2014) · BMJ Evidence-Based Medicine · doi:10.1136/eb-2014-101741 · Cited by 13
A strategy to find novel candidate anti-Alzheimer’s disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants
Chen, B., Li, W., Wang, G., Li, G., Liu, J.-Q., Zheng, J., Wang, Q., Li, H., Dai, S., & Huang, J. (2018) · PeerJ · doi:10.7717/peerj.4756 · Cited by 13
Utility of the Dependence Scale in dementia: validity, meaningfulness, and health economic considerations
Zhu, C. W., Bruinsma, B., & Stern, Y. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0414-7 · Cited by 14
Vitamin E: an overview
Khallouki, F., Owen, R. W., Akdad, M., Bouhali, B. E., Silvente‐Poirot, S., & Poirot, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811907-5.00001-4 · Cited by 13
Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities
Li, J., Wang, L., Zhang, X., Shi, J., Zhu, Y. Z., Wang, H., Zhu, X., Zhu, Q., & Luo, J. (2025) · Biomolecules · doi:10.3390/biom15091290 · Cited by 13
A review of pomegranate supplementation: A promising remedial avenue for Alzheimer's disease
Ullah, A., Khan, A., Ahmed, S., Irfan, H. M., Hafiz, A. A., Jabeen, K., Alruwaili, M., Alotaibi, M., Naeem, W. A., Khan, A., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22483 · Cited by 13
Study on the Pharmacological Mechanism of Icariin for the Treatment of Alzheimer’s Disease Based on Network Pharmacology and Molecular Docking Techniques
Wang, D., Zheng, J., Sun, X., Xie, L., & Yang, Y. (2023) · Metabolites · doi:10.3390/metabo14010001 · Cited by 12
Plant-derived extracellular vesicles as potential smart nano drug delivery systems for antioxidant vitamins C and E in Alzheimer's disease
Jiyah, A., Muhammad, S. A., Ibrahim, A., Bulama, I., Ibrahim, A., Abbas, A. Y., Imam, M. U., Saidu, Y., & Bilbis, L. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105618 · Cited by 13
Dietary Strategies to Mitigate Alzheimer’s Disease: Insights into Antioxidant Vitamin Intake and Supplementation with Microbiota–Gut–Brain Axis Cross-Talk
Ngah, W. Z. W., Ahmad, H. F., Ankasha, S. J., Makpol, S., & Tooyama, I. (2024) · Antioxidants · doi:10.3390/antiox13121504 · Cited by 12
Cytoprotection against beta-amyloid (Aβ) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells
Youn, P., Chen, Y., & Furgeson, D. Y. (2015) · Neuroscience Research · doi:10.1016/j.neures.2014.12.015 · Cited by 12
Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
Cai, M., & Yang, E. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606480 · Cited by 11
The significance of oxidative stress in the pathophysiology of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Walker, M., Hall, K. H., Peppercorn, K., & Tate, W. P. (2022) · Medical Research Archives · doi:10.18103/mra.v10i9.3050 · Cited by 13
Targeting Metals in Alzheimer’s Disease: An Update
Du, B., Chen, K., Wang, W., & Lei, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240140 · Cited by 13
The potential role of nutritional components in improving brain function among patients with Alzheimer’s disease: a meta-analysis of RCT studies
Albrahim, T. I. (2020) · Neurosciences · doi:10.17712/nsj.2020.1.20190037 · Cited by 11
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid life
Denton, D. A., Abraham, R. P., Al-Assaf, A. S., Rutjes, A. W., Chong, L. Y., Anderson, J. L., Malik, M., & Tabet, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011904 · Cited by 11
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
Singh, S. P., Yang, F., Sivils, A., Cegielski, V., & Chu, X. (2022) · Biomolecules · doi:10.3390/biom12070996 · Cited by 11
A micronutrient mixture with collagen peptides, probiotics, cannabidiol, and diet may reduce aging, and development and progression of age-related alzheimer’s disease, and improve its treatment
Prasad, K. N. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111757 · Cited by 13
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
Loeffler, D. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240212 · Cited by 12
From Epidemiology to Epigenetics: Evidence for the Importance of Nutrition to Optimal Health Development Across the Life Course
Taylor-Baer, M., & Herman, D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-47143-3_18 · Cited by 12
Past and Future of Drug Treatments for Alzheimer's Disease
Kim, S. Y. (2018) · 신경정신의학 · doi:10.4306/jknpa.2018.57.1.30 · Cited by 11
Oxygen Sensing in Neurodegenerative Diseases: Current Mechanisms, Implication of Transcriptional Response, and Pharmacological Modulation
Rey, F., Messa, L., Maghraby, E., Casili, G., Ottolenghi, S., Barzaghini, B., Raimondi, M. T., Cereda, C., Cuzzocrea, S., Zuccotti, G., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0046 · Cited by 11
Garcinoic Acid
Kluge, S., Schubert, M., Schmölz, L., Birringer, M., Wallert, M., & Stefan Lorkowski, A. (2016) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63932-5.00009-7 · Cited by 10
The Role of Vitamin E in Slowing Down Mild Cognitive Impairment: A Narrative Review
Lakhan, R., Sharma, M., Batra, K., & Beatty, F. (2021) · Healthcare · doi:10.3390/healthcare9111573 · Cited by 10
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in late life
Al-Assaf, A. S., Denton, D. A., Abraham, R. P., Rutjes, A. W., Chong, L. Y., Anderson, J. L., Malik, M., & Tabet, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011906 · Cited by 11
The listed, delisted, and sustainability of therapeutic medicines for dementia patients: the study is specific to South Korea
Lee, J. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02209-3 · Cited by 11
The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany
Bohlken, J., Jacob, L., van den Bussche, H., & Kostev, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180382 · Cited by 11
Association of Dietary and Supplement Intake of Antioxidants with Risk of Dementia: A Meta-Analysis of Cohort Studies
Zhao, R., Han, X., Jiang, S., Zhao, W., Liu, J., Zhang, H., Mao, X., Zhang, M., Lei, L., & You, H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220909 · Cited by 11
Harnessing nutrients and natural products for sustainable drug development against aging
Ding, F., Yu, Y., Zhang, Y., Wei, S., Han, J. H., Li, Z., Jiang, H., Ryu, D., Park, W., Ha, K., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1579266 · Cited by 11
Shifting Perspectives on the Role of Tocotrienol vs. Tocopherol in Brain Health: A Scoping Review
Razali, R. A., Ngah, W. Z. W., Makpol, S., Yanagisawa, D., Kato, T., & Tooyama, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136339 · Cited by 9
Effect of replacing a portion of fish meal with unfermented and/or fermented soybean meal on the growth performance, antioxidant and immunity capacity and related gene expression in juvenile Coho Salmon, Oncorhynchus kisutch
Zhang, Q., Wang, J., Yang, Q., Xu, L., Xu, J., Liu, Y., & Tong, T. (2023) · Journal of the World Aquaculture Society · doi:10.1111/jwas.12998 · Cited by 9
The Quest for Neurodegenerative Disease Treatment—Focusing on Alzheimer’s Disease Personalised Diets
Palimariciuc, M., Balmuș, I.-M., Gireadă, B., Ciobica, A. S., Chiriță, R., Iordache, A.-C., Apostu, M., & Dobrin, R. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45020098 · Cited by 9
Neuronal injury from cardiac arrest: aging years in minutes
Cherry, B., Sumien, N., & Mallet, R. T. (2014) · AGE · doi:10.1007/s11357-014-9680-x · Cited by 9
Essential nutrient requirements of the elderly
Skully, R. (2014) · Nutrition and Dietary Supplements · doi:10.2147/nds.s35381 · Cited by 9
The Hepatic Fate of Vitamin E
Schmölz, L., Schubert, M., Kluge, S., Birringer, M., Wallert, M., & Lorkowski, S. (2018) · InTech eBooks · doi:10.5772/intechopen.79445 · Cited by 9
Protective role of Gum Arabic(Acacia Senegal) on oxidative stress in diabetic and adenine induced chronic renal failure in rats
El-Tobgy, K. M. K. (2019) · International Journal of ChemTech Research · doi:10.20902/ijctr.2019.120126 · Cited by 9
Is Coffee the Cause or the Cure? Conflicting Nutrition Messages in Two Decades of Online New York Times’ Nutrition News Coverage
Ihekweazu, C. (2021) · Health Communication · doi:10.1080/10410236.2021.1950291 · Cited by 10
Nutritional interventions for preventing cognitive decline in patients with mild cognitive impairment and Alzheimer's disease: A comprehensive network meta-analysis and Mendelian Randomization study
He, Q., Bennett, A. N., Zhang, C., Zhang, J. Y., Tong, S., & Chan, K. H. K. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.03.040 · Cited by 10
Mitochondrial Damage and Autophagy Dysregulation in Alzheimer’s Disease: Mechanisms and Therapeutic Opportunities
Yu, Q., Li, L., Yu, S., Han, J., Cheng, Q., Cui, Z., Chen, H., Li, M., & Lu, Z. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04490-z · Cited by 9
Mitochondrial drug delivery systems
Hubbard, W. B., Vekaria, H. J., & Sullivan, P. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00017-6 · Cited by 8
Effect of Vitamin E on Transcriptomic Alterations in Alzheimer’s Disease
Ekeuku, S. O., Murshid, N. M., Shukri, S. N., Sahardi, N. F. N. M., & Makpol, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512372 · Cited by 9
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and “First Do No Harm” Part II
Moyad, M. A. (2020) · Current Urology Reports · doi:10.1007/s11934-020-0967-4 · Cited by 7
Current evidence of the role of vitamin E in prolonging a healthy life
Traber, M. G. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0020 · Cited by 8
Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
Mohapatra, T. K., Nayak, R. R., Ganeshpurkar, A., Tiwari, P. K., & Kumar, D. (2025) · Ibrain · doi:10.1002/ibra.12197 · Cited by 8
Scoping Review: The Role of Tocotrienol-Rich Fraction as a Potent Neuroprotective Agent
Yunita, E., Nasaruddin, M. L., Ramli, N. Z., Yahaya, M. F., & Damanhuri, H. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167691 · Cited by 8
Memantine: updates from the past decade and implications for future novel therapeutic applications
Danysz, W., Hansen, N., Wiltfang, J., Kornhuber, J., Scheschonka, A., & Gravius, A. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03017-8 · Cited by 7
Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease
Nagaraju, P. G., Ashwini, S., & G., P. P. C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2092446 · Cited by 7
The role of α-tocopherol in the prevention and treatment of Alzheimer's disease
Pelczarski, M., Wolaniuk, S., Zaborska, M., Sadowski, J., Sztangreciak-Lehun, A., & Bułdak, R. J. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05214-1 · Cited by 10
Flavonoid-enrich extract of Autranella congolensis (Sapotaceae) protects against aluminium chloride-mediated Alzheimer’s disease-like oxidative stress in rat through the antioxidant properties
Ngoumen, D. J. N., Mandob, D. E., Ella, F. A., Ambamba, B. D. A., Nanhah, J. V. K., Fonkoua, M., & Ngondi, J. L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01142-x · Cited by 8
Ferroptosis and its modulators: A raising target for cancer and Alzheimer’s disease
Singh, G., Kesharwani, P., Singh, G. K., Kumar, S., Putta, A., & Modi, G. P. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117564 · Cited by 7
Evaluation of an Evidence-based Medicine Educational Program for Pharmacists and Pharmacy Students
Shimizu, T., Ueda, M., Toyoyama, M., Ohmori, S., & Takagaki, N. (2017) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.16-00179 · Cited by 7
Vitamin E in Health and Disease
Packer, L. (2023) · CRC Press eBooks · doi:10.1201/9781003418160 · Cited by 7
Synergistic Antioxidant Effects of C3G-Enriched Oryza sativa L. cv. RD83 Extract and α-Tocopherol Against H2O2-Induced Oxidative Stress in SH-SY5Y Cells
Mairuae, N., & Palachai, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136490 · Cited by 6
Ferroptosis in neurological diseases: moving towards therapeutic intervention
Tuo, Q., Bush, A. I., & Lei, P. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03445-2 · Cited by 11
Association of Vitamin E and Cognitive Decline in Older Adults with and without the APOE ɛ 4 Allele: A Biracial Population-Based Community Study
Liu, X., Finno, C. J., Beck, T. L., Dhana, K., Tangney, C., Desai, P., Krueger, K. R., Evans, D. A., & Rajan, K. B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230797 · Cited by 6
Bioactive compounds and dietary patterns in Alzheimer's disease
Christimann, G., dos Santos, G. R., & Sattler, J. A. G. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251319048 · Cited by 6
Effects of Curcumin on Neuroinflammation in Animal Models and in Patients with Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_7 · Cited by 6
How to Distinguish between Statistically Significant Results and Clinically Relevant Results
Bennett, D. (2016) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000445411 · Cited by 6
Electrochemical Biosensors for Antioxidants
García‐Guzmán, J. J., López-Iglesias, D., Marin, M., Lete, C., Lupu, S., Santander, J. M. P., & Aguilera, L. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815743-5.00004-4 · Cited by 6
Antioxidant modulation in restoring mitochondrial function in neurodegeneration
Arrozi, A. P., Ngah, W. Z. W., Yusof, Y. A. M., Damanhuri, H. A., & Makpol, S. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1178261 · Cited by 7
Naturally Occurring Antioxidants
Ronzio, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00097-2 · Cited by 6
Vitamin E Intake and Serum Levels in the General Population: A Global Perspective
Péter, S., Eggersdorfer, M. L., & Weber, P. (2019) · Springer eBooks · doi:10.1007/978-3-030-05315-4_13 · Cited by 6
The Role of Vitamin E in Aging and Alzheimer’s Disease
Eckert, G. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-05315-4_24 · Cited by 6
Nutraceuticals for Cognitive Dysfunction
Gupta, R. C., Doss, R. B., Srivastava, A., Lall, R., & Sinha, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_26 · Cited by 6
Dietary nutrients and their control of the redox bioenergetic networks as therapeutics in redox dysfunctions sustained pathologies
Bhotla, H. K., Meyyazhagan, A., Pappuswamy, M., Park, S., Arumugam, V. A., Pushparaj, K., Rengasamy, K. R. R., Liu, W., & Balasubramanian, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105709 · Cited by 8
Combining a high DHA multi-nutrient supplement with aerobic exercise: Protocol for a randomised controlled study assessing mobility and cognitive function in older women
Fairbairn, P., Tsofliou, F., Johnson, A. J., & Dyall, S. C. (2019) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2019.04.001 · Cited by 6
Natural Health Products in the Prevention and Management of Alzheimer’s Disease: A Systematic Review of Randomized Clinical Trials
Conti, V., Zarrella, A., Donnarumma, D., Pagano, A., Mazza, I., Stefano, A. D., Gallo, F., Landri, V. D., Pascale, D. D., Manzo, V., et al. (2025) · Applied Sciences · doi:10.3390/app15073513 · Cited by 5
Diagnostic and inclusion criteria in Alzheimer's disease clinical trials: A systematic review of the past decade
Liu, Y., Chen, S., Li, S., Pei, Z., Fan, S., & Guo, Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251362444 · Cited by 6
Calafate (Berberis buxifolia Lam.) Berry as a Source of Bioactive Compounds with Potential Health-Promoting Effects: A Critical Review
Ortíz, J., Vergara, C., Toledo, T., Zura‐Bravo, L., Flores, M., Barrera, C., & Lemus-Mondaca, R. A. (2025) · Antioxidants · doi:10.3390/antiox14111272 · Cited by 5

Authors: Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., Prieto, S., Chen, P., Loreck, D. J., Trapp, G., Bakshi, R. S., Mintzer, J. E., Heidebrink, J. L., Vidal-Cardona, A., Arroyo, L. M., Cruz, A. R., Zachariah, S., Kowall, N. W., Chopra, M. P., Craft, S., Thielke, S., Turvey, C. L., Woodman, C., Monnell, K. A., Gordon, K., Tomaska, J., Segal, Y., Peduzzi, P. N., & Guarino, P. D.
Affiliations: Minneapolis VA Health Care System (US)
James J. Peters VA Medical Center (US)
William S. Middleton Memorial Veterans Hospital (US)
Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico
Louis Stokes Cleveland VA Medical Center (US)
Washington DC VA Medical Center (US)
University of Pennsylvania (US)
Miami VA Healthcare System (US)
VA Maryland Health Care System (US)
VA North Texas Health Care System (US)
Medical University of South Carolina (US)
VA Ann Arbor Healthcare System (US)
VA Caribbean Healthcare System, San Juan, Puerto Rico
VA Caribbean Healthcare System (PR)
Bay Pines VA Healthcare System (US)
VA Boston Healthcare System (US)
University of Washington (US)
University of Iowa (US)
W. G. (Bill) Hefner VA Medical Center (US)
Yale University (US)
ORCID: Sano, Mary
Asthana, Sanjay
Vertrees, Julia E.
Schellenberg, Gerard D.
McCarten, J. Riley
Chen, Peijun
Mintzer, Jacobo E.
Heidebrink, Judith L.
Kowall, Neil W.
Craft, Suzanne
Thielke, Stephen
Turvey, Carolyn L.
Woodman, Catherine
Tomaska, Julie
Peduzzi, Peter N.
Guarino, Peter D.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2014-01-01
Volume: 311
Issue: 1
Pages: 33
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2013.282834
PMC: PMC4109898
OpenAlex: W2128047032
Cited by: 628
References: 40
Citations by year: 2026: 34 · 2025: 41 · 2024: 36 · 2023: 54 · 2022: 56 · 2021: 53 · 2020: 47 · 2019: 47 · 2018: 61 · 2017: 48 · 2016: 50 · 2015: 55 · 2014: 44
FWCI: 35.66
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (P50AG005138, P30AG013846, P50AG005136)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords: Alzheimer's disease, vitamin E, alpha-tocopherol, memantine, functional decline, activities of daily living, acetylcholinesterase inhibitors, disease progression, caregiver burden, neuropsychiatric symptoms, adverse events, infections and infestations, combination therapy, veterans, older adults, cognitive decline, mortality, quality of life, cost-effectiveness
MeSH terms: Activities of Daily Living, Aged, Aged, 80 and over, Alzheimer Disease, Antioxidants, Cholinesterase Inhibitors, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Memantine, Middle Aged, Severity of Illness Index, Vitamin E, Dopamine Agents, Treatment Outcome, Caregivers, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks